Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
BioCryst Pharmaceuticals
BCRX
$2.49B
| $4.1M | 0.01% |
545,021
-44,059
| -7% | -$334K |
|
1577
Diana Shipping
DSX
$309M
| $4.09M | 0.01% |
2,088,213
-79,100
| -4% | -$169K |
|
1578
Huron Consulting
HURN
$2.42B
| $4.08M | 0.01% |
32,858
-500
| -1% | -$58.6K |
|
1579
Bioventus
BVS
$1.2B
| $4.08M | 0.01% |
388,700
+800
| +0.2% | +$9.46K |
|
|
AVDL
1580
DELISTED
Avadel Pharmaceuticals
AVDL
| $4.08M | 0.01% |
387,800
+366,300
| +1,704% | +$4.45M |
|
1581
Atea Pharmaceuticals
AVIR
$410M
| $4.08M | 0.01% |
1,216,600
+9,500
| +0.8% | +$31.6K |
|
1582
NexGen Energy
NXE
$6.97B
| $4.05M | 0.01% |
+614,200
| New | +$4.63M |
|
1583
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $4.05M | 0.01% |
37,100
+11,400
| +44% | +$1.29M |
|
1584
APA Corp
APA
$14.2B
| $4.04M | 0.01% |
+175,077
| New | +$4.09M |
|
1585
Landstar System
LSTR
$6.45B
| $4.03M | 0.01% |
23,440
-14,900
| -39% | -$2.72M |
|
1586
iShares Convertible Bond ETF
ICVT
$7.67B
| $4.02M | 0.01% |
47,303
-7,697
| -14% | -$662K |
|
1587
BK Technologies
BKTI
$277M
| $4.01M | 0.01% |
116,970
-12,600
| -10% | -$384K |
|
1588
Installed Building Products
IBP
$6.39B
| $4M | 0.01% |
22,800
+17,900
| +365% | +$3.89M |
|
1589
Bausch Health
BHC
$2.43B
| $3.99M | 0.01% |
495,172
+468,572
| +1,762% | +$3.86M |
|
1590
York Water
YORW
$541M
| $3.99M | 0.01% |
121,936
+100
| +0.1% | +$3.56K |
|
1591
Monro
MNRO
$359M
| $3.99M | 0.01% |
160,779
+5,700
| +4% | +$156K |
|
1592
American Express Global Business Travel
GBTG
$4.94B
| $3.99M | 0.01% |
429,520
-182,380
| -30% | -$1.56M |
|
|
PPL
1593
PPL Corp
PPL
$27.1B
| $3.99M | 0.01% |
122,774
+105,574
| +614% | +$3.48M |
|
1594
Intuitive Surgical
ISRG
$139B
| $3.98M | 0.01% |
7,630
-84,700
| -92% | -$44.1M |
|
1595
Thomson Reuters
TRI
$44.9B
| $3.98M | 0.01% |
24,417
+3,446
| +16% | +$580K |
|
1596
DigitalBridge
DBRG
$2.94B
| $3.97M | 0.01% |
351,776
+63,600
| +22% | +$855K |
|
1597
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.3B
| $3.96M | 0.01% |
+45,000
| New | +$3.89M |
|
|
HONE
1598
DELISTED
HarborOne Bancorp
HONE
| $3.94M | 0.01% |
333,341
-97,800
| -23% | -$1.24M |
|
1599
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
| $3.94M | 0.01% |
68,000
-22,700
| -25% | -$1.37M |
|
1600
JPMorgan Equity Premium Income ETF
JEPI
$46.3B
| $3.94M | 0.01% |
68,500
-39,300
| -36% | -$2.33M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.